bioRxivBioengineeringPreprint
Prime editing enables precise genome editing in mouse liver and retina
H. Jang, J. H. Shin, D. H. Jo, J. H. Seo, G. Yu, R. Gopalappa, S.-R. Cho, J. H. Kim, H. H. Kim
Abstract
Prime editing can induce any small-sized genetic change without donor DNA or double strand breaks. However, it has not been investigated whether prime editing is possible in postnatal animals. Here we delivered prime editors 2 and 3 into a mouse model of hereditary tyrosinemia, a genetic liver disease, using hydrodynamic injection, which corrected the disease-causing mutation and rescued the phenotype. We also achieved prime editing in the retina and retina pigment epithelium in wild-type mice by delivering prime editor 3 using trans-splicing adeno-associated virus. Deep sequencing showed that unintended edits at or near the target site or off-target effects were not detectable except for low levels (0% to 1.2%) of indels when PE3, but not PE2, was used. Our study suggests that precise, prime editor-mediated genome editing is possible in somatic cells of adult animals.
- organism: mouse
- assay: whole-genome sequencing
- research focus: variant calling
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prime editing primarily induces undesired outcomes in mice
Tomomi Aida, Jonathan J. Wilde, … Guoping Feng·bioRxiv·Aug 6, 2020
- Treatment of a metabolic liver disease by in vivo prime editing in mice
Desirée Böck, Tanja Rothgangl, … Gerald Schwank·bioRxiv·Aug 17, 2021
- Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice
P. Liu, S. Liang, … W. Xue·Nature CommunicationsPeer-reviewed·Apr 9, 2021
- Treatment of a genetic liver disease in mice through transient prime editor expression
T. Rothgangl, E. I. Ioannidi, … G. Schwank·bioRxiv·Jan 22, 2024
- Optimized nickase- and nuclease-based prime editing in human and mouse cells
Fatwa Adikusuma, Caleb Lushington, … Paul Quinton Thomas·Nucleic Acids ResearchPeer-reviewed·Sep 16, 2021
- Ex vivo therapeutic base and prime editing using chemically derived hepatic progenitors in a mouse model of tyrosinemia type 1